These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8750634)

  • 41. Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine.
    Robertson LE; Denny AW; Huh YO; Plunkett W; Keating MJ; Nelson JA
    Cancer Chemother Pharmacol; 1996; 37(5):445-50. PubMed ID: 8599867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fludarabine and fatal hemolytic anemia].
    López L; del Villar V; Pascual T
    Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
    [No Abstract]   [Full Text] [Related]  

  • 43. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
    Efremov DG; Ivanovski M; Burrone OR
    Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
    Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
    Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune cytopenias in chronic lymphocytic leukemia.
    Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
    Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 49. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
    Cheson BD; Vena DA; Barrett J; Freidlin B
    J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transformation of chronic lymphocytic leukemia to myelodysplastic syndrome: case presentation and review of the literature].
    Telek B; Pfliegler G; Reményi G; Méhes L; Batár P; Udvardy M
    Orv Hetil; 2009 Apr; 150(15):689-92. PubMed ID: 19362917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
    Zaja F; Vianelli N; Sperotto A; Patriarca F; Tani M; Marin L; Tiribelli M; Candoni A; Baccarani M; Fanin R
    Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic lymphocytic leukemia presenting in association with aplastic anemia.
    Zonder JA; Keating M; Schiffer CA
    Am J Hematol; 2002 Dec; 71(4):323-7. PubMed ID: 12447965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug-induced hemolytic anemia].
    Wautier JL; Rouger P
    Transfus Clin Biol; 2001 Aug; 8(4):377-80. PubMed ID: 11642029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.
    Reagan JL; Castillo JJ
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):151-60. PubMed ID: 21342032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
    Kimura A; Hyodo H; Nakata Y; Kuramoto A
    Am J Hematol; 1993 May; 43(1):47-50. PubMed ID: 8317461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia.
    Cabrelle A; Maschio N; Carraro S; Frezzato F; Binotto G; Gattazzo C; Miorin M; Agostini C; Zambello R; Pandolfi F; Semenzato G; Trentin L
    J Biol Regul Homeost Agents; 2009; 23(4):239-50. PubMed ID: 20003763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When and how to treat chronic lymphocytic leukemia.
    Dighiero G; Binet JL
    N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
    [No Abstract]   [Full Text] [Related]  

  • 60. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
    Frankel AE; Fleming DR; Hall PD; Powell BL; Black JH; Leftwich C; Gartenhaus R
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3555-61. PubMed ID: 14506141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.